3020.9000 2.20 (0.07%)
NSE May 23, 2025 15:31 PM
Volume: 101.3K
 

3020.90
0.07%
Karvy
GlaxoSmithKline Pharmaceuticals Ltd: Outlook & Valuation: We downgrade our revenue estimates for FY21E by 4.3% to Rs 34.5 bn and introduce our revenues for FY22E.
Number of FII/FPI investors decreased from 347 to 340 in Mar 2025 qtr
More from GlaxoSmithKline Pharmaceuticals Ltd.
Recommended